James Paul Rickey Insider Profile
4 Followers
James Paul Rickey, Chief Financial Officer at Braveheart Bio, Inc., holds 703.58K shares in Braveheart Bio, Inc. (Ticker: BRVE), holds 0.00 shares in Immune Design (Ticker: IMDZ), holds 0.00 shares in Alpine Immune Sciences (Ticker: ALPN). Most recently, James Paul Rickey Bought ― shares of Braveheart Bio, Inc. on Aug 07, 2026 for an estimated value of $499.99K.
James Paul Rickey Braveheart Bio, Inc. (BRVE)Chief Financial Officer
Braveheart Bio, Inc. (BRVE)
Chief Financial Officer
Ranked #43,267 out of 108,921 Corporate Insiders
Profitable Transactions
1 out of 3 Profitable Transactions
Average Return
+6.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of James Paul Rickey's holdings
Insider Roles
Chief Financial Officer
Roles that James Paul Rickey holds in companies
Most Profitable Insider Trade
Stock:
Alpine Immune Sciences
(ALPN)
(ALPN)
Rating:Informative Sell
Date:Jan 04, 2022 - Jan 04, 2023
Return:+43.20%
The most profitable trade made by James Paul Rickey
James Paul Rickey's Trading History
Braveheart Bio, Inc.
Aug 07, 2026
Chief Financial Officer
Informative Buy
499.99K
$18.74M
Immune Design
―
―
―
$0.00
Alpine Immune Sciences
May 20, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see James Paul Rickey's performance on stock
You May Also Like
James Paul Rickey insider profile FAQ
What is the percentage of profitable transactions made by James Paul Rickey?
The percentage of profitable transactions made by James Paul Rickey is 33%.
What is the average return per transaction made by James Paul Rickey?
The average return per transaction made by James Paul Rickey is 6.60%.
What stocks does James Paul Rickey hold?
James Paul Rickey holds: BRVE, IMDZ, ALPN stocks.
What was James Paul Rickey’s latest transaction?
James Paul Rickey latest transaction was an Informative Buy of $499.99K.
What was James Paul Rickey's most profitable transaction?
James Paul Rickey’s most profitable transaction was an Informative Sell of ALPN stock on January 4, 2022. The return on the trade was 43.20%.
What is James Paul Rickey's role in Braveheart Bio, Inc.?
James Paul Rickey's role in Braveheart Bio, Inc. is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.